About
Aims and scope
BMJ Sexual & Reproductive Health is a multiprofessional journal that promotes sexual and reproductive health and wellbeing, and best contraceptive practice, worldwide. It publishes research, debate and comment to inform policy and practice, and recognises the importance of professional-patient partnership.
The journal was previously known as Journal of Family Planning and Reproductive Health Care.
Ownership
BMJ Sexual & Reproductive Health is co-owned by BMJ and the Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists.
Journal Statistics
| Acceptance Rate | 30% for original research articles (2018) |
|---|---|
| Time from submission to first decision | 52 days |
| Time from acceptance to online publication | 17 days |
| Frequency | Quarterly |
| Impact Factor | 2.027 (2017) – as Journal of Family Planning and Reproductive Health Care |
| CiteScore | 0.84 (2017) – as Journal of Family Planning and Reproductive Health Care |
| Indexed by | Web of Science Core Collection: Science Citation Index Expanded, Social Sciences Citation Index; Current Contents: Social and Behavioural Sciences, MEDLINE (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Medica), Google Scholar |
| Launch date | 1974 |
| Print ISSN | 2515-1991 |
| Online ISSN | 2515-2009 |
Contact information
For all contact information please refer to the contact us page.
For authors
Please refer to the Instructions for authors
Subscriptions
To advertise
Rights and permissions
Affiliations
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.